标题
Mechanism of tumor cells escaping from immune surveillance of NK cells
作者
关键词
-
出版物
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
Volume 42, Issue 3, Pages 187-198
出版商
Informa UK Limited
发表日期
2020-03-30
DOI
10.1080/08923973.2020.1742733
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- JAK/STAT proteins and their biological impact on NK cell development and function
- (2019) Alexander Vargas-Hernández et al. MOLECULAR IMMUNOLOGY
- Progenitors from the central nervous system drive neurogenesis in cancer
- (2019) Philippe Mauffrey et al. NATURE
- The mechanism of anti-PD-L1 antibody efficacy against PD-L1 negative tumors identifies NK cells expressing PD-L1 as a cytolytic effector
- (2019) Wenjuan Dong et al. Cancer Discovery
- Inhibition of Lung Tumor Development in ApoE Knockout Mice via Enhancement of TREM-1 Dependent NK Cell Cytotoxicity
- (2019) Yong Sun Lee et al. Frontiers in Immunology
- The Tim-3-Galectin-9 Pathway and Its Regulatory Mechanisms in Human Breast Cancer
- (2019) Inna M. Yasinska et al. Frontiers in Immunology
- Human natural killer cells mediate adaptive immunity to viral antigens
- (2019) Rana Nikzad et al. Science Immunology
- Natural killer cells involved in tumour immune escape of hepatocellular carcinomar
- (2019) Chen Han et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Metastatic-niche labelling reveals parenchymal cells with stem features
- (2019) Luigi Ombrato et al. NATURE
- IL-17 constrains natural killer cell activity by restraining IL-15–driven cell maturation via SOCS3
- (2019) Xuefu Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Therapeutic blockade of activin-A improves NK cell function and antitumor immunity
- (2019) Jai Rautela et al. Science Signaling
- NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
- (2018) Jan P. Böttcher et al. CELL
- Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor
- (2018) Alexander D. Barrow et al. CELL
- Dysfunction of Natural Killer Cells by FBP1-Induced Inhibition of Glycolysis during Lung Cancer Progression
- (2018) Jingjing Cong et al. Cell Metabolism
- NKp46 Receptor-Mediated Interferon-γ Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis
- (2018) Ariella Glasner et al. IMMUNITY
- CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms
- (2018) Xian-Yang Li et al. JOURNAL OF CLINICAL INVESTIGATION
- Epithelial-mesenchymal transition leads to NK cell–mediated metastasis-specific immunosurveillance in lung cancer
- (2018) Peter J. Chockley et al. JOURNAL OF CLINICAL INVESTIGATION
- Inhibition of IL-6-JAK/Stat3 signaling in castration-resistant prostate cancer cells enhances the NK cell-mediated cytotoxicity via alteration of PD-L1/NKG2D ligand levels
- (2018) LiJun Xu et al. Molecular Oncology
- Combination of Asiatic Acid and Naringenin Modulates NK Cell Anti-cancer Immunity by Rebalancing Smad3/Smad7 Signaling
- (2018) Guang-Yu Lian et al. MOLECULAR THERAPY
- Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity
- (2018) Qing Zhang et al. NATURE IMMUNOLOGY
- DKK2 imparts tumor immunity evasion through β-catenin-independent suppression of cytotoxic immune-cell activation
- (2018) Qian Xiao et al. NATURE MEDICINE
- A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments
- (2018) Kevin C. Barry et al. NATURE MEDICINE
- Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell–driven tumor immunity
- (2018) Lucas Ferrari de Andrade et al. SCIENCE
- NK Cells Control Tumor-Promoting Function of Neutrophils in Mice
- (2018) Keisuke Ogura et al. Cancer Immunology Research
- CD16A Activation of NK Cells Promotes NK Cell Proliferation and Memory-Like Cytotoxicity against Cancer Cells
- (2018) Jens H.W. Pahl et al. Cancer Immunology Research
- NK Cell–Specific CDK8 Deletion Enhances Antitumor Responses
- (2018) Agnieszka Witalisz-Siepracka et al. Cancer Immunology Research
- Targeting PKCδ as a Therapeutic Strategy against Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant Lung Cancer
- (2018) Pei-Chih Lee et al. CANCER CELL
- Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
- (2018) Pascale André et al. CELL
- Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response
- (2018) Assaf Marcus et al. IMMUNITY
- New Insights Into the Role of Qa-2 and HLA-G Non-classical MHC-I Complexes in Malignancy
- (2018) Istéfani L. da Silva et al. Frontiers in Immunology
- Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers
- (2017) Y Liu et al. ONCOGENE
- NK cell-based immunotherapy for cancer
- (2017) Fang Fang et al. SEMINARS IN IMMUNOLOGY
- IL-21-mediated reversal of NK cell exhaustion facilitates anti-tumour immunity in MHC class I-deficient tumours
- (2017) Hyungseok Seo et al. Nature Communications
- Smad3 promotes cancer progression by inhibiting E4BP4-mediated NK cell development
- (2017) Patrick Ming-Kuen Tang et al. Nature Communications
- BPTF inhibits NK cell activity and the abundance of natural cytotoxicity receptor co-ligands
- (2017) Kimberly Mayes et al. Oncotarget
- Tumor-derived IL-18 induces PD-1 expression on immunosuppressive NK cells in triple-negative breast cancer
- (2017) In Hae Park et al. Oncotarget
- Melanoma-associated fibroblasts decrease tumor cell susceptibility to NK cell-mediated killing through matrix-metalloproteinases secretion
- (2017) Linda Ziani et al. Oncotarget
- Exosomes Derived From Natural Killer Cells Exert Therapeutic Effect in Melanoma
- (2017) Liya Zhu et al. Theranostics
- Tumor-Derived Mesenchymal Stem Cells Use Distinct Mechanisms to Block the Activity of Natural Killer Cell Subsets
- (2017) Sabine Galland et al. Cell Reports
- Endothelial cells express NKG2D ligands and desensitize antitumor NK responses
- (2017) Thornton W Thompson et al. eLife
- Role of NOX2-Derived Reactive Oxygen Species in NK Cell–Mediated Control of Murine Melanoma Metastasis
- (2017) Ebru Aydin et al. Cancer Immunology Research
- Human CD56dimCD16dim Cells As an Individualized Natural Killer Cell Subset
- (2017) Mathieu Amand et al. Frontiers in Immunology
- Targeting cytokine signaling checkpoint CIS activates NK cells to protect from tumor initiation and metastasis
- (2017) Eva M. Putz et al. OncoImmunology
- Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment
- (2017) Susanne M. Steggerda et al. Journal for ImmunoTherapy of Cancer
- Enhancing NK cell-mediated cytotoxicity to cisplatin-resistant lung cancer cells via MEK/Erk signaling inhibition
- (2017) Li Yang et al. Scientific Reports
- A comparison of cancer stem cell markers and nonclassical major histocompatibility complex antigens in colorectal tumor and noncancerous tissues
- (2016) Rabia Bilge Özgül Özdemir et al. Annals of Diagnostic Pathology
- Voluntary Running Suppresses Tumor Growth through Epinephrine- and IL-6-Dependent NK Cell Mobilization and Redistribution
- (2016) Line Pedersen et al. Cell Metabolism
- Liver-infiltrating CD11b−CD27− NK subsets account for NK-cell dysfunction in patients with hepatocellular carcinoma and are associated with tumor progression
- (2016) Qiong-Fang Zhang et al. Cellular & Molecular Immunology
- miR-146a negatively regulates NK cell functions via STAT1 signaling
- (2016) Dongqing Xu et al. Cellular & Molecular Immunology
- IL-21 Enhances Natural Killer Cell Response to Cetuximab-Coated Pancreatic Tumor Cells
- (2016) Elizabeth L. McMichael et al. CLINICAL CANCER RESEARCH
- Immunosuppressive activities of adenosine in cancer
- (2016) Bertrand Allard et al. CURRENT OPINION IN PHARMACOLOGY
- M2-polarized and tumor-associated macrophages alter NK cell phenotype and function in a contact-dependent manner
- (2016) Tamara Krneta et al. JOURNAL OF LEUKOCYTE BIOLOGY
- CIS is a potent checkpoint in NK cell–mediated tumor immunity
- (2016) Rebecca B Delconte et al. NATURE IMMUNOLOGY
- TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway
- (2016) Sébastien Viel et al. Science Signaling
- Present Yourself! By MHC Class I and MHC Class II Molecules
- (2016) Kenneth L. Rock et al. TRENDS IN IMMUNOLOGY
- Exercise-Dependent Regulation of NK Cells in Cancer Protection
- (2016) Manja Idorn et al. TRENDS IN MOLECULAR MEDICINE
- High circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma
- (2016) Mir Alireza Hoda et al. Oncotarget
- TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway
- (2016) Sébastien Viel et al. Science Signaling
- NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?
- (2016) Claudia Cantoni et al. Journal of Immunology Research
- Natural killer cells require monocytic Gr-1+/CD11b+ myeloid cells to eradicate orthotopically engrafted glioma cells
- (2016) Gregory J. Baker et al. OncoImmunology
- Prognostic impact of the expression of NCR1 and NCR3 NK cell receptors and PD-L1 on advanced non-small cell lung cancer
- (2016) Laetitia Fend et al. OncoImmunology
- T Cell Antigen Receptor Recognition of Antigen-Presenting Molecules
- (2015) Jamie Rossjohn et al. Annual Review of Immunology
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- TLR7/8 agonists promote NK–DC cross-talk to enhance NK cell anti-tumor effects in hepatocellular carcinoma
- (2015) Zhixia Zhou et al. CANCER LETTERS
- Transcription Factor Foxo1 Is a Negative Regulator of Natural Killer Cell Maturation and Function
- (2015) Youcai Deng et al. IMMUNITY
- The Clinical Significance of Abnormal Tim-3 Expression on NK Cells from Patients with Gastric Cancer
- (2015) Zhenxin Wang et al. IMMUNOLOGICAL INVESTIGATIONS
- Low expression of Bin1, along with high expression of IDO in tumor tissue and draining lymph nodes, are predictors of poor prognosis for esophageal squamous cell cancer patients
- (2015) Yunlong Jia et al. INTERNATIONAL JOURNAL OF CANCER
- Cdk8deletion in theApcMinmurine tumour model represses EZH2 activity and accelerates tumourigenesis
- (2015) Mark L McCleland et al. JOURNAL OF PATHOLOGY
- Ezh2 regulates differentiation and function of natural killer cells through histone methyltransferase activity
- (2015) Jie Yin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Versatile functions for IL-6 in metabolism and cancer
- (2015) Jan Mauer et al. TRENDS IN IMMUNOLOGY
- Cetuximab Reconstitutes Pro-Inflammatory Cytokine Secretions and Tumor-Infiltrating Capabilities of sMICA-Inhibited NK Cells in HNSCC Tumor Spheroids
- (2015) Stephan Klöss et al. Frontiers in Immunology
- MHC-I modulation due to changes in tumor cell metabolism regulates tumor sensitivity to CTL and NK cells
- (2015) Elena Catalán et al. OncoImmunology
- Hypoxic tumor-derived microvesicles negatively regulate NK cell function by a mechanism involving TGF-β and miR23a transfer
- (2015) Guy Berchem et al. OncoImmunology
- HLA-G in human early pregnancy: Control of uterine immune cell activation and likely vascular remodeling
- (2015) Philippe Le Bouteiller Biomedical Journal
- MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape
- (2015) Paula Codo et al. Oncotarget
- Loss of STAT3 in murine NK cells enhances NK cell-dependent tumor surveillance
- (2014) D. Gotthardt et al. BLOOD
- The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8 + T Cell Effector Function
- (2014) Robert J. Johnston et al. CANCER CELL
- Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer
- (2014) George C. Prendergast et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Natural Killer Cells Eradicate Galectin-1-Deficient Glioma in the Absence of Adaptive Immunity
- (2014) G. J. Baker et al. CANCER RESEARCH
- Tumor-released Galectin-3, a Soluble Inhibitory Ligand of Human NKp30, Plays an Important Role in Tumor Escape from NK Cell Attack
- (2014) Wei Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TGF- Utilizes SMAD3 to Inhibit CD16-Mediated IFN- Production and Antibody-Dependent Cellular Cytotoxicity in Human NK Cells
- (2014) R. Trotta et al. JOURNAL OF IMMUNOLOGY
- A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER)
- (2014) Yuankai Shi et al. Journal of Thoracic Oncology
- NK Cell Phenotypic Modulation in Lung Cancer Environment
- (2014) Shi Jin et al. PLoS One
- TGF- -inducible microRNA-183 silences tumor-associated natural killer cells
- (2014) S. S. Donatelli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IDO is highly expressed in breast cancer and breast cancer-derived circulating microvesicles and associated to aggressive types of tumors by in silico analysis
- (2014) M. T. Isla Larrain et al. TUMOR BIOLOGY
- Targeting Cancer-Derived Adenosine:New Therapeutic Approaches
- (2014) A. Young et al. Cancer Discovery
- Killer Immunoglobulin-like Receptors and Tumor Immunity
- (2014) D. M. Benson et al. Cancer Immunology Research
- Reversal of NK-Cell Exhaustion in Advanced Melanoma by Tim-3 Blockade
- (2014) I. P. da Silva et al. Cancer Immunology Research
- NK cell-based immunotherapy for malignant diseases
- (2013) Min Cheng et al. Cellular & Molecular Immunology
- Suppression of cytokine signaling: The SOCS perspective
- (2013) Edmond M. Linossi et al. CYTOKINE & GROWTH FACTOR REVIEWS
- On the role of 25-hydroxycholesterol synthesis by glioblastoma cell lines. Implications for chemotactic monocyte recruitment
- (2013) Gerald Eibinger et al. EXPERIMENTAL CELL RESEARCH
- Galectin-9 Functionally Impairs Natural Killer Cells in Humans and Mice
- (2013) L. Golden-Mason et al. JOURNAL OF VIROLOGY
- CDK8-Mediated STAT1-S727 Phosphorylation Restrains NK Cell Cytotoxicity and Tumor Surveillance
- (2013) Eva Maria Putz et al. Cell Reports
- GITR Ligand Provided by Thrombopoietic Cells Inhibits NK Cell Antitumor Activity
- (2012) T. Placke et al. JOURNAL OF IMMUNOLOGY
- Downregulation of indoleamine-2,3-dioxygenase in cervical cancer cells suppresses tumor growth by promoting natural killer cell accumulation
- (2012) NAOTO SATO et al. ONCOLOGY REPORTS
- How melanoma cells inactivate NK cells
- (2012) Gabriella Pietra et al. OncoImmunology
- Platelet-Derived MHC Class I Confers a Pseudonormal Phenotype to Cancer Cells That Subverts the Antitumor Reactivity of Natural Killer Immune Cells
- (2011) T. Placke et al. CANCER RESEARCH
- A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans
- (2011) Shigeru Tsuboi et al. EMBO JOURNAL
- CD11b and CD27 reflect distinct population and functional specialization in human natural killer cells
- (2011) Binqing Fu et al. IMMUNOLOGY
- EGFR Inhibitors Enhanced the Susceptibility to NK Cell-mediated Lysis of Lung Cancer Cells
- (2011) Hyunsu Kim et al. JOURNAL OF IMMUNOTHERAPY
- A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development
- (2010) E. Eckelhart et al. BLOOD
- A Novel Translocation Breakpoint within the BPTF Gene Is Associated with a Pre-Malignant Phenotype
- (2010) Yosef Buganim et al. PLoS One
- Activin-A attenuates several human natural killer cell functions
- (2009) N. C. Robson et al. BLOOD
- Platelet-Derived Transforming Growth Factor- Down-Regulates NKG2D Thereby Inhibiting Natural Killer Cell Antitumor Reactivity
- (2009) H.-G. Kopp et al. CANCER RESEARCH
- Nuclear CDKs Drive Smad Transcriptional Activation and Turnover in BMP and TGF-β Pathways
- (2009) Claudio Alarcón et al. CELL
- Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer
- (2009) Tetsuya Mitsudomi et al. FEBS Journal
- Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients
- (2008) Lun Cai et al. CLINICAL IMMUNOLOGY
- Expression and prognosis role of indoleamine 2,3-dioxygenase in hepatocellular carcinoma
- (2008) Ke Pan et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- IL-15 trans-presentation promotes human NK cell development and differentiation in vivo
- (2008) Nicholas D. Huntington et al. JOURNAL OF EXPERIMENTAL MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More